Drug Information

Drug General Information
Drug ID
D03KXQ
Former ID
DNC013247
Drug Name
L-valyl-L-proline benzylamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527857]
Structure
Download
2D MOL

3D MOL
Formula
C17H25N3O2
Canonical SMILES
CC(C)C(C(=O)N1CCCC1C(=O)NCC2=CC=CC=C2)N
InChI
1S/C17H25N3O2/c1-12(2)15(18)17(22)20-10-6-9-14(20)16(21)19-11-13-7-4-3-5-8-13/h3-5,7-8,12,14-15H,6,9-11,18H2,1-2H3,(H,19,21)/t14-,15-/m0/s1
InChIKey
LCASDNOITBVYIV-GJZGRUSLSA-N
PubChem Compound ID
11645153
Target and Pathway
Target(s) Tripeptidyl-peptidase II Target Info Inhibitor [527857]
Reactome Antigen processing: Ubiquitination & Proteasome degradation
References
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.